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ORIGINAL ARTICLE
Background/Aims: In type 2 diabetic patients, coronary artery disease (CAD) is usually detected at an
advanced stage due to a lack of symptoms. The aim of this study was to define which clinical parameters or non-
invasive tests predict CAD in asymptomatic type 2 diabetic patients.
Methods: One hundred fourteen asymptomatic type 2 diabetic patients were divided into two groups based on
the number of cardiovascular disease (CVD) risk factors (group A ≥2, group B ≤1). Treadmill exercise ECG tests
(TMT) were conducted in all cases, and coronary artery angiography was performed on TMT-positive patients.
Clinical parameters, diabetic status, and coronary angiographic findings were analyzed.
Results: The prevalence of CAD was 41.0% in group A and 16.7% in group B. The number of risk factors was
significantly correlated with the prevalence of CAD, but not with the severity of CAD. Multivariate analysis
showed that family history of CAD (odds ratio [OR]=9.41; 95% confidence interval [CI], 1.60-55.49) and diabetes
duration ≥10 years (OR=3.28; 95% CI, 1.29-8.84) were independent CAD risk factors in asymptomatic patients.
Conclusions: We recommend a routine screening for CAD in type 2 diabetic patients who have a longer (≥10
years) diabetic duration or a family history of CAD, even if they are asymptomatic for CAD. (Korean J Intern Med
2009;24:183-189)
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INTRODUCTION
Coronary artery disease (CAD) accounts for 70-80% of
mortalities in diabetic patients, and type 2 diabetes
mellitus (DM) is an important risk factor [1]. CAD risk for
those with type 2 DM is as great as that associated with a
previous history of myocardial infarction [1-3]. However,
progressive CAD is asymptomatic in many cases of type 2
DM, which makes it difficult to diagnose at the proper
time [4]. The diagnosis of asymptomatic CAD in type 2
diabetic patients is largely made based on the recommen-
dations of the American Diabetes Association (ADA). The
ADA recommends that DM patients perform a treadmill
exercise test (TMT) or a coronary artery angiography if
they have additional cardiovascular disease (CVD) risk
factors [5]. However, clinically severe CAD is often
discovered in patients with fewer risk factors. 
To overcome these limitations, several previous studies
were conducted to develop more sensitive diagnostic
methods, such as single photon emission computerized
tomography (SPECT) [6] and multi-detector coronary
CT [7]. However, more sensitive diagnostic approaches
may be unrealistic because clinicians care for asympto-
matic diabetic patients on an outpatient basis. Thus, no
proper diagnostic test exists for the early diagnosis of
asymptomatic CAD. In the present study, TMT andcoronary arterial angiography (CAG) were performed in
asymptomatic type 2 diabetic patients, regardless of the
number of CVD risk factors present, to determine the best
CAD predictor in these patients.
METHODS
Subjects 
This study was performed prospectively from 2000 to
2006. One hundred fourteen type 2 DM patients were
enrolled based on a detailed history obtained from all
type 2 DM patients who visited the department of
endocrinology, Dankook University Hospital. Patients
were excluded if they 1) had clinical symptoms of typical
angina or chest pain, or had undergone tests for CVD
(TMT, exercise echocardiography, myocardial SPECT,
and CAG); 2) had abnormal ECG findings during CVD
tests such as TMT, myocardial SPECT, and CAG; and 3)
were previously diagnosed or treated for non-CAD heart
diseases such as an inherited cardiac disorder, cardiac
valve disease, heart failure, or arrhythmia. We also excluded
cases with ambiguous information related to CVD. 
TMT was performed in all patients regardless of the
numbers of CVD risk factors. Coronary arterial angiography
was conducted in patients with positive or equivocal TMT
results, for example, test discontinuation due to a decline
in exercise ability. Results were taken from the first test if
patients underwent tests more than once. This study was
approved by the Hospital Ethics Committee, and informed
consent for coronary angiography was obtained from all
patients.
Evaluation of clinical factors
Age, gender, height, and body weight were measured.
The body mass index (BMI) was calculated at the time of
testing. Obesity was defined as a BMI ≥25. A family
history of type 2 DM was defined as a diagnosis of DM
among first degree relatives. A family history of CAD was
defined as a diagnosis of myocardial infarction or angina
pectoris among first relatives. Those with a smoking
history were defined as smokers regardless of current
smoking status or amount of smoking. Hypertension was
defined as taking anti-hypertensive medication, a systolic
pressure ≥140 mmHg, or a diastolic pressure ≥90 mmHg
on two separate occasions, as defined by the World Health
Organization. The five CVD risk factors were smoking,
hypertension, dyslipidemia, a family history of CAD, and
macro-micro albuminuria, based on the 1998 ADA recom-
mendations [5]. According to the number of risk factors,
114 patients were divided into two groups: Group A with
≥2 risk factors, and Group B with ≤1.
Type 2 DM patients were defined as: 1) diagnosed and
received treatment for DM, 2) random blood glucose level
≥200 mg/dl with diabetic symptoms based on the ADA
diagnostic criteria, or 3) fasting blood glucose level of ≥126
mg/dl. Duration of type 2 DM was defined as the time
lapse from diagnosis to the time of CAD testing and was
measured in years. Diabetic retinopathy was defined as 1)
a diagnosis by fundoscopic examination (by a professional
ophthalmologist) and 2) a history of photocoagulation
treatment due to diabetic retinopathy. Diabetic neuropathy
was defined as the presence of neuropathic symptoms
(paresthesia, pain), signs of sensory loss (loss of light
touch, pinprick, cold, vibration in the toes), abnormal
findings on the Semmes-Weinstein monofilament test,
and nerve conduction velocity measurements. Diabetic
nephropathy was defined as the appearance of abnormal
urinary albumin levels; microalbuminuria (30-299 mg
albumin/24 hours) and macroalbuminuria (>300 mg
albumin/24 hours).
Biochemistry tests
Fasting plasma glycosylated hemoglobin (HbA1c), total
cholesterol, triglyceride, and high-density lipoprotein
(HDL)-cholesterol were measured. The Friedewald
equation (LDL-cholesterol=total cholesterol-HDL
cholesterol - triglyceride/5) was used to calculate low-
density lipoprotein (LDL)-cholesterol if triglyceride
was <400. LDL-cholesterol was directly measured if
triglyceride was ≥400. According to the ADA guideline [5],
dyslipidemia was defined as a total cholesterol level ≥240
mg/dL, an HDL-cholesterol level of 35 mg/dL or less, or
an LDL-cholesterol level ≥160 mg/dL.
Treadmill exercise ECG test
TMT was performed according to the Bruce protocol
using a 12-lead ECG. TMT was terminated if the heart
rate (220-age) reached 85% of target, the patient
complained of significant chest pain, systolic blood
pressure dropped by 10 mmHg or more during the test,
the patient developed a neurologic impairment such as
dizziness or vertigo, the patient had blood flow impair-
ment such as cyanosis, the patient had continuous
ventricular arrhythmia, or the ST segment declined or
became elevated more than 1.0-1.5 mm [8]. A positive
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horizontal down-sloping or up-sloping ST-segment
depression that occurred at least 0.08 seconds after the J
point. Findings were considered “uncertain” in cases with
a positive treadmill exercise test and an inappropriate
outcome, such as reduced exercise capacity or disruptions
in heart rate. Coronary arterial angiography was conducted
in the cases showing positive or uncertain findings during
TMT.
Coronary arterial angiography
The femoral artery (usually the right) was catheterized
using the Seldinger technique. The femoral approach was
preferred because all of the patients in this study showed
positive findings on the TMT, and they had a high
probability of percutaneous coronary intervention. Two or
more Judkins coronary catheters were used for diagnostic
coronary angiography, and proper interventional instru-
ments were used if coronary intervention was necessary.
Angiographic data were obtained using a fully digital
Annova 2100 (GE Health Care, Waukesha, WI, USA) and
analyzed using a QCA algorithm (GE stenosis analysis
algorithm, GE Health Care). CAD was considered in case of
more than 50% stenosis. In cases with stenosis >80%
(severe case), a Percutaneous coronary intervention (PCI)
including balloon angioplasty and stent insertion was
performed with or without the aid of intravascular
ultrasound. All patients who underwent PCI were closely
observed in a sub-intensive care unit.
Statistical analysis
SPSS (version 11.5 for Windows) was used for the
statistical analysis. When a parameter showed a skewed
distribution, median values between the two groups were
compared with the nonparametric Mann-Whitney U-test.
Mean±standard deviations (SD) were compared using an
unpaired Student’s t-test for normally distributed
parameters. The CAD incidence based on the number of
risk factors was analyzed using the chi-square test.
Logistical regression analysis was used to identify CAD
risk factors in asymptomatic patients. P values <0.05 were
considered significant.  
RESULTS
Patient characteristics
The clinical characteristics of all asymptomatic patients
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Table 1. Clinical characteristics, diabetic complications, and risk factors for cardiovascular disease in the subjects
Total CAD
(n=114) Yes  (n=38) No  (n=76) p value
Age, years 57.2±10.7 60.5±8.0 55.5±11.5 <0.05
Male/female 65 / 49 18 / 20 47 / 29 NS
BMI, kg/m
2 25.1±3.4 24.9±2.7 25.2±3.7 NS
DM duration, years 10.2±7.6 13.4±7.0 8.4±7.5 <0.001
DM family history 45 (39.5) 17 (44.7) 28 (36.8) NS
Retinopathy 43 (37.7) 18 (47.3) 25 (32.8) NS
Neuropathy 43 (37.7) 18 (47.3) 25 (32.8) NS
Hypertension 60 (52.6) 27 (71.1) 33 (43.4) <0.05
Smoking 55 (48.2) 16 (42.1) 39 (51.3) NS
CAD family history 9 (7.9) 7 (18.4) 2 (2.6) <0.001
Proteinuria 36 (31.6) 16 (42.1) 20 (26.3) NS
Risk factors 2.0±1.0 2.5±0.9 1.8±0.9 <0.001
HbA1c, % 9.0± 2.0 8.6±1.7 9.1±2.2 NS
Creatinine, mg/dL 1.1±0.6 1.2±0.9 1.0±0.3 NS
Total cholesterol, mg/dL 198.3± 41.4 207.5±39.1 193.7±42.0 NS
HDL cholesterol, mg/dL 45.0±11.3 48.0±11.3 43.6±11.0 NS
LDL cholesterol, mg/dL 116.1± 36.0 123.2±38.0 112.4±37.6 NS
Triglyceride, mg/dL 216.7±140.0 204.9±134.9 224.4±124.5 NS
Values are number (percentage) or mean±SD.
P values refer to comparisons between patients with and without CAD based on coronary angiographic findings.
CAD, coronary artery disease; BMI, body mass index; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; HDL, high-density
lipoprotein; LDL, low-density lipoprotein.(male, n=65; female, n=49) are shown in Table 1. The
mean BMI was 25.1, and approximately half of the
patients were overweight. The mean duration of DM was
10.2 years. Dyslipidemia was the most prevalent CVD risk
factor. The average number of CVD risk factors was 2.0
(Table 1).
To identify CAD-related risk factors, we compared
clinical CVD risk factors between patients with CVD and
patients without CVD (Table 1). Those with CAD were
older and they had a longer duration of DM, hypertension,
a more frequent family history of CAD, and a larger number
of CVD risk factors. No significant differences were found
in gender, obesity, complications from chronic DM, smok-
ing status, HbA1c, creatinine, total cholesterol, HDL-
cholesterol, LDL-cholesterol, or triglyceride values (Table
1). The odds ratios for the risk factors were (in order); a
family history of CAD, type 2 DM duration of ≥10 years,
≥2 risk factors, hypertension, and age ≥59 years (Table 2).
In the multivariate analysis, only a family history of CAD
and DM duration ≥ 10 years were significantly correlated with
the presence of CAD in asymptomatic patients (Table 2).
Risk factor analysis
The 114 subjects were classified by the number of CAD
risk factors, as suggested by the ADA [5]. Seventy-eight
patients (68.4%) had two or more risk factors (group A),
and 36 patients (31.6%) had one or fewer risk factors
(group B). No significant differences in age, BMI, compli-
cation status, blood glucose level, family history, or DM
duration were found between groups A and B (Table 3).
The CAD prevalence in groups A and B was 41.0% and
16.7%, respectively (p<0.01). These data confirm that the
number of risk factors was correlated with CAD incidence.
However, when we compared the two groups by CVD
severity, group A had 21 (65.6%) severe cases (≥80%
stenosis) and group B had four (66.7%). Thus, CVD
severity was not different between the two groups,
suggesting that even asymptomatic patients with few risk
factors could have severe CAD.
Analysis of patients with one or no risk factors
According to the ADA recommendations, diagnostic
evaluation of patients in group B with one or fewer risk
factors would not be required. If we followed the ADA
recommendation, we would have missed six CVD patients
who had confirmed CAD by coronary artery angiography.
Thus, we further analyzed the clinical characteristics of
these six patients in detail (Table 4). Their mean age was
64.5 years, and the mean DM duration was 16.2 years.
Furthermore, five had diabetic retinopathy, and four had
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Table 2. Odds ratios for coronary artery disease risk
factors
Univariate Multivariate
OR (95% CI) OR (95% CI)
Age >59 years 2.68 (1.18-6.08) 2.56 (0.95-6.88)
Hypertension 3.20 (1.39-7.37) 1.94 (0.72-5.21)
CAD family history 8.36 (1.64-42.49) 9.41 (1.60-55.49)*
DM duration ≥10 years 3.78 (1.58-9.05) 3.38 (1.29-8.84)*
Risk factors ≥2 3.48 (1.30-9.32) 2.08 (0.68-9.41)
OR, odds ratio; CI, confidence interval; CAD, coronary artery
disease; DM, diabetes mellitus.
*p<0.05.
Table 3. Comparison between patients who had greater than two (group A) or one or fewer (group B)
cardiovascular disease risk factors
Group A Group B p value
(n=78) (n=36)
Age, years 57.6±9.9 56.2±12.3 NS
Male/female 46/32 19/17 NS
BMI, kg/m
2 25.2±2.8 24.8±4.4 NS
DM family history 29 (37.2) 16 (44.4) NS
DM duration, years 10.3±7.5 9.6±8.0 NS
Retinopathy 33 (42.3) 10 (27.8) NS
Neuropathy 30 (38.5) 13 (36.1) NS
HbA1c, %  9.1±2.1 8.7±2.0 NS
Incidence of CAD 32 (41.0) 6 (16.7) 0.010
Severe CAD cases* 21 (65.6) 4 (66.7) NS
Values are number (percentage) or mean±SD.
NS, not significant; BMI, body mass index; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; CAD, coronary artery disease.
*Severe CAD cases refers to the number (%) of patients who underwent a reperfusion procedure due to 80% or greater stenosis.diabetic neuropathy. Four were treated with insulin, and
the other two patients were taking oral hypoglycemic
drugs. Blood glucose control was poor in all six (mean
HbA1c, 9.6%); however, none of the patients had abnormal
echocardiographic findings. Three had a positive TMT
result, and three an inappropriate TMT result, which
was due to the patient’s request to discontinue treadmill
exercise because of poor exercise capacity. Coronary
arterial angiography showed significant stenosis (≥80%)
in four patients who required reperfusion therapy. Five of
the six patients had multiple CAD, and two of the five had
stenosis in three vessels (Table 4). In summary, except for
one relatively young male with a 30-year smoking history
(patient 6), the remaining five were elderly with a long
duration of DM, poor glucose control, and various diabetic
microvascular complications.
DISCUSSION
We found that the diagnostic approach that considers
the number of CVD risk factors may fail to detect CVD in a
substantial number of patients. Cost-benefit considerations
probably make it impossible to adopt an active diagnostic
approach in all asymptomatic patients. However, based
on our results, we recommend an active CAD evaluation
in older patients with a disease duration of ≥10 years and
a family history of CAD. 
CAD may have already progressed in DM patients at
the time of diagnosis [9,10] or may present as heart or
multiple organ failure, which have high mortality rates
[11,12]. Nevertheless, a CAD diagnosis is often delayed,
especially in asymptomatic cases. The prevalence of
asymptomatic CAD in DM patients is diverse and
reportedly ranges from 9 to 75% [13-17]. In the present
study, the prevalence of CAD was 29.8% among asympto-
matic patients and 16.7% among patients with one or no
risk factors. These figures are somewhat lower than are
those reported previously, partly because of the strict
selection of asymptomatic patients; we tried to exclude all
patients with any CAD-related symptoms based on a
careful review by physicians.
Diabetes itself is one of the Framingham risk factors for
ischemic heart disease. We used the ADA recommendation
to search for risk factors because the guideline for
“asymptomatic” diabetic patients is more specific and
widely used in practice. The diagnostic approach based
on the numbers of CVD risk factors in asymptomatic
patients was devised in 1998 by the American Heart
Association and at a Consensus Development Conference
of the American Diabetic Association [5]. This approach
is based on an epidemiologic study in which patients
who had more than one of the following five CVD risk
factors  were more likely to have CAD: smoking,  dyslipi-
demia, hypertension, family history of CAD, and  macro-
micro albuminuria. The relationship between the number
of CVD risk factors and incidence is also clear in our study;
a distinct difference was found between the group with
two or more and that with one or fewer risk factors.
However, when we compared CAD severity using the
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Table 4. Clinical characteristics of the six patients in group B
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Sex F F F M F M
Age, years 65 65 71 71 66 49
BMI, kg/m
2 27.4 21.7 24.0 23.5 24.2 18.6
DM duration, years 20 20 15 10 30 2
Risk factor HTN HTN DysL Smoking DysL Smoking
HbA1c, % 9.8 9.2 9.0 7.5 10.9 11
DM treatment  Insulin Insulin OHA OHA Insulin Insulin
Retinopathy + + + + + - 
Neuropathy + + + - -  - 
Nephropathy - -  - -  -  - 
Echocardiography Normal Normal Normal Normal Normal Normal
CAG findings Multi Single Multi Multi Multi Multi
Reperfusion + - -  -  + +
BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; DysL, Dyslipidemia; HbA1c, glycosylated hemoglobin; OHA, oral
hypoglycemic agent; CAG, coronary arteriography; Multi, multi-vessel disease; Single, single vessel disease. number of patients who had undergone reperfusion
therapy due to significant occlusions, no significant
difference was observed between those who underwent
reperfusion therapy and those who did not (65.5 vs. 66.7%).
That is, CAD incidence in patients with a lower number
of risk factors is relatively small, but disease severity is not
negligible, which is why we must make efforts to identify
CAD early.
We focused on the six asymptomatic patients with one
or no CVD risk factors because these patients would
previously have been considered to be a low risk group and
warrant only clinically observation. Most of these patients
(Table 4, case 1~5) were >60 years old, and the DM
duration was more than 10 years. These five patients were
not able to pass the second stage of the TMT, so a decline
in TMT exercise capacity may be an important sign. The
remaining patient (Table 4, case 6) was a relatively young
man with no evidence of microvascular complications.
This patient had distin-guished clinical features compared
to the other five, and the main factor in this case might be
atherogenic or vascular in nature rather than DM. We
suggest that the clinical characteristics of these six patients
could be used as reference data, even though they do not
constitute a general parameter for a diagnostic approach
due to the small number of patients. 
The duration of DM is not included among CAD risk
factors in the ADA recommendations. However, debate on
the relationship between duration and CAD continues,
and several recent reports have concluded that a positive
correlation exists [13, 16-18]. Our study confirmed that it
is advisable to consider the DM duration as a primary
CAD risk factor, regardless of symptoms. Other risk
factors, such as dyslipidemia, smoking [19], and macro-
micro albuminuria [13,20] are well-known CVD risk
factors, although we found no significant correlations in
asymptomatic patients. It is unclear whether this
discrepancy is specific to asymptomatic patients or is due
to the selection process. We recruited subjects from an
outpatient clinical setting, and not from among patients
who had undergone coronary angiography or who had
CAD symptoms. Hence, we believe that our patients
mainly consisted of truly asymptomatic patients in a
typical clinical setting. 
Several attempts have been made to overcome the
delayed detection of CAD using more sensitive diagnostic
techniques. In a recent large-scale study [7], more sig-
nificant coronary stenosis, multivessel involvement, and
greater plaque burden were observed in subjects with
impaired fasting glucose or diabetes by MDCT, even
though they were asymptomatic. Without question, recent
tools are more promising to detect asymptomatic patients
earlier with higher accuracy. The problem is applicability.
Although these sensitive diagnostic tools have important
roles, they apply only to referral hospitals. Accordingly,
TMT appears to be the most effective method for CAD
screening in an outpatient clinical setting. In fact, it is the
most efficient means to screen for asymptomatic CAD
[13,15]. Our study results are limited due to the small
number of subjects; thus, a large-scale future study using
improved diagnostic techniques is warranted. 
In summary, type 2 DM patients had a greater risk for
CVD if they were old, had a longer DM duration, or had a
family history of CVD, even if they were asymptomatic.
We recommend that diagnostic tests be performed to
detect CVD in these asymptomatic patients.
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